Home › Funds › Stonepine Capital Management, LLC › CRBP

Stonepine Capital Management, LLC position in CRBP

CORBUS PHARMACEUTICALS HLDGS · Health Care

Stonepine Capital Management, LLC reported holding 95,000 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$648K, representing 0.50% of its reported portfolio and ranking #40 among its reported holdings. Stonepine Capital Management, LLC has disclosed CRBP holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)95.00K sh
Reported value held$647.90K
Portfolio Weight0.50%
First reportedQ1 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's CRBP position evolved

Stonepine Capital Management, LLC first disclosed a stake in CRBP in Q1 2025 at 35,000 shares (US$186K). The position peaked in Q2 2026 at 425,000 shares, worth US$4.0M. Across 5 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 95,000 shares valued at US$648K — a reduction of -330,000 shares quarter over quarter.. Notable position changes include a 78% trim in Q3 2026 (shares fell 50% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 35.00K $185.85K New
Q4 2025 389.92K $3.17M New
Q1 2026 383.46K $3.60M Reduce
Q2 2026 425.00K $3.99M Add
Q3 2026 95.00K $647.90K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRBP and 13F data

CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 21 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$2.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRBP

All CRBP fund holders →

FAQ

How long has Stonepine Capital Management, LLC held CRBP?

Stonepine Capital Management, LLC has disclosed CRBP holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

What is Stonepine Capital Management, LLC's current position in CRBP?

As of Q3 2026, Stonepine Capital Management, LLC holds 95.00K shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $647.90K, representing 0.50% of its reported portfolio and ranking #40.

Has Stonepine Capital Management, LLC been buying or selling CRBP?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC reduced its position in CRBP. The position peaked in Q2 2026 at 425.00K shares.

Which other funds hold CRBP?

Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.